Stem Cell Transplantation in Neonates and Infants

  • Carolina Witchmichen Penteado Schmidt
Chapter

Abstract

Although stem cell transplantation (SCT) is rare in neonates or infants, there has been some research reporting an encouraging survival rate; as well as there are studies pointing SCT in infants as a controversial treatment [41, 42, 45].

References

  1. 41.
    Ibagy A, Silva DB, Seiben J, et al. Acute lymphoid leukemia in infants: 20 years of experience. J Pediatr. 2013;89(1):64–9.CrossRefGoogle Scholar
  2. 42.
    Hunger SP, Loh KM, Baker KS, Schultz KR. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia. Biol Blood Marrow Transplant. 2009;15(1):79–83.CrossRefGoogle Scholar
  3. 45.
    Masetti R, Vendemini F, Zama D, Biagi C, Pession A, Locatelli F. Acute myeloid leukemia in infants: biology and treatment. Front Pediatr. 2015;3:37.CrossRefGoogle Scholar
  4. 35.
    Gassas A, Ashraf K, Zaidman I, et al. Hematopoietic stem cell transplantation in infants. Pediatr Blood Cancer. 2015;62(3):517–21.CrossRefGoogle Scholar
  5. 30.
    Pieters R, Schrappe M, Valsecchi MG, Biondi A, et al. INTERFANT-06: International collaborative treatment protocol for infants under one year with acute lymphoblastic or biphenotypic leukemia. Stichting KInderoncologie Nederland. 2016. https://www.skion.nl/workspace/uploads/Interfant-06_version16b_1aug2016_stop-Rand_MEC.pdf. Accessed 13 Jan 2017.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Carolina Witchmichen Penteado Schmidt
    • 1
  1. 1.CuritibaBrazil

Personalised recommendations